The average annual disposable income of the nation’s richest families last year was 6.13 times higher than that of the poorest families, which is slightly lower than the 6.17 times recorded in 2011, indicating that the nation’s wealth gap has remained relatively steady, the Directorate-General of Budget, Accounting and Statistics (DGBAS) said yesterday.
The 6.13 times also marked the lowest level since 2008, DGBAS data showed.
If social welfare subsidies and tax benefits were excluded, the ratio between the highest-income group and the lowest-income group would have reached 7.7 times last year — its lowest level since 2007, DGBAS said.
“The nation still saw economic growth last year [from 2011], albeit at a slowing pace, with the jobless rate also slightly improving during that period, which helped to narrow the wealth gap,” DGBAS section head Chuang Wen-kuan (莊文寬) told a press conference.
The government’s move to raise eight social welfare allowances last year, which cost the government more than NT$10 billion (US$333.31 million) per year, was also a major factor behind the narrowing of the income gap, Chuang said.
More people applied for retirement payouts last year than in 2011 and withdrew NT$430 million from the labor insurance fund amid concerns about the fund’s long-term efficiency, up from the NT$260 million withdrawn in 2011, which helped contract the gap in terms of nominal figures, DGBAS data showed.
The DGBAS has conducted an annual survey of family incomes and expenditures since 1964 to keep tabs on wealth distribution.
The survey divides families into five brackets in terms of annual disposable income, with the top 20 percent defined as the richest and the bottom 20 percent as the poorest.
The latest survey found that the average annual disposable income of the richest families was NT$1.85 million last year, compared with NT$301,000 for those in the poorest bracket.
NOTABLE SHIFT: By 2030, 50% of all laptops would be assembled in Southeast Asia, while Taiwan would still mostly focus on research and development, a report said Global laptop and desktop computer supply chains are expected to shift significantly away from China in the next 10 years, a Market Intelligence & Consulting Institute (MIC, 產業情報研究所) report said. By 2030, only 40 percent of global laptop production would remain in China, said the report, which was released on Thursday. “The reshuffling of the global supply chain will be one of the most important trends in the next 10 years,” the institute said in the report. “In the long run, key component makers will follow laptop assemblers in moving out of China.” The Taipei-based institute predicted most key component makers
Yageo Corp (國巨), the world’s third-largest supplier of multilayer ceramic capacitors, has formed a strategic alliance with Hon Hai Precision Industry Co (鴻海精密) to develop key electronic components for electric vehicles and digital healthcare, it said yesterday. The alliance is to help Yageo boost its revenue from high-end components for vehicles and industrial, medical and aerospace devices, as well as those used in 5G and Internet-of-Things devices, the company said. The companies signed the strategic alliance agreement at Yageo’s headquarters in New Taipei City’s Sindian District (新店). Their cooperation is to start this quarter, the companies said in a joint statement. “Through the cooperation
SUPPLY CONSTRAINTS: The transferred orders might not provide an immediate revenue boost given local chipmakers’ high utilization rates, a senior analyst said Shares of local contract chipmakers yesterday rose as much as the 10 percent daily limit, as investors bet on orders being transferred from Semiconductor Manufacturing International Corp (SMIC, 中芯國際) after the US imposed export restrictions on the Chinese chipmaker. United Microelectronics Corp (UMC, 聯電) shares soared 10 percent to close at NT$27.5 as 380 million shares changed hands on the Taiwan Stock Exchange. UMC is the world’s No. 3 foundry by revenue, followed by SMIC, according to data from market researcher TrendForce Corp (集邦科技). UMC has product and customer portfolios similar to those of SMIC, TrendForce said, adding that UMC offers 14-nanometer and
‘IMPORTANT MILESTONE’: The firm expects to launch the generic of Revlimid in the US after March 2022. It has already launched the product in some European countries Lotus Pharmaceutical Co Ltd (美時化學製藥) has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for lenalidomide, the company said in a statement on Friday. The ANDA approval is for 2.5mg, 5mg, 10mg, 20mg and 25mg capsules of lenalidomide, which is a generic version of blood cancer drug Revlimid developed by Celgene Corp. It is the first product fully developed and manufactured in Lotus’ facilities in Taiwan. Lotus expects to launch the product in the US — based on its patent litigation settlement with Celgene last year — some time after March